Nippon Steel has finalized its $14.9 billion acquisition of U.S. Steel, buying all shares at $55 each in a landmark deal supported by President Donald Trump. The Japanese steelmaker’s 18-month effort to secure U.S. regulatory approval faced intense political resistance, but succeeded after agreeing to a rare “golden share” arrangement with the U.S. government.
Under this agreement, the U.S. President gains the right to appoint one independent board member and veto key decisions, including job relocations, plant closures, and changes to U.S. Steel’s name or headquarters. This level of federal oversight, aimed at safeguarding national security, raises concerns about foreign investor sentiment.
White House spokesperson Kush Desai called the deal historic, emphasizing protections for economic and national interests. Nippon Steel CEO Eiji Hashimoto thanked Trump for enabling the acquisition and expressed enthusiasm for expanding U.S. operations.
The golden share was key to passing scrutiny by the Committee on Foreign Investment in the U.S. (CFIUS). Legal experts warn that such political involvement in M&A reviews may deter future foreign investment.
Despite initial opposition from both the Biden and Trump administrations, and a lawsuit over alleged bias in the national security review, Trump ultimately approved the deal via executive order after a final 45-day review.
Nippon Steel plans to invest $11 billion in U.S. Steel by 2028, including $1 billion for a new mill. The deal lifts Nippon’s crude steel capacity to 86 million tons, inching closer to its 100-million-ton target and enabling access to the U.S. market without facing the 50% tariffs applied to other foreign steel producers.
The United Steelworkers union, still wary of the deal, vowed to monitor compliance with Nippon’s commitments moving forward.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border 



